These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9732941)

  • 21. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
    Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
    Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
    Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathologic observations on chronic hepatitis C therapy with interferon-alpha].
    Jármay K; Lonovics J; Schaff Z
    Orv Hetil; 2003 Jul; 144(27):1325-30. PubMed ID: 12908145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.
    Di Martino V; Thevenot T; Colin JF; Boyer N; Martinot M; Degos F; Coulaud JP; Vilde JL; Vachon F; Degott C; Valla D; Marcellin P
    Gastroenterology; 2002 Dec; 123(6):1812-22. PubMed ID: 12454838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.
    Hino K; Okita K
    J Antimicrob Chemother; 2004 Jan; 53(1):19-22. PubMed ID: 14657083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of children with α-1 antitrypsin deficiency.
    Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heterozygotic alpha-1 antitrypsin deficiency. A case report].
    Bataller Sifre R; Vicente Ull R; Llombart Bosch A; Carda Batalla C; Gabriel Botella F; Bataller Alberola R; Galindo Puerto J
    Gastroenterol Hepatol; 1996; 19(6):313-6. PubMed ID: 8754420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The value of the Pi system phenotype in alpha 1-antitrypsin deficiency].
    Fragoso Arbelo T; Barrios García B; Castañeda Guillot C; Cendan Cordovi A; Shumkov Nikolov G; Sagaro González E; Ruiz Mendez A; Dehesa Enriquez A; Soler Franco J
    Acta Gastroenterol Latinoam; 1986; 16(2):75-80. PubMed ID: 3495088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liver diseases in children and their relatives with homozygous and heterozygous alpha 1-antitrypsin deficiency].
    Deutsch J; Becker H; Dubs R; Mutz I; Paschke E; Schober P; Maurer G; Fueger GF
    Wien Klin Wochenschr; 1987 Feb; 99(3):84-91. PubMed ID: 3495072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alpha-1-antitrypsin deficiency and liver diseases].
    Bartók K; Korányi G; Bartók K; Nádor K; Hegedũs C
    Morphol Igazsagugyi Orv Sz; 1989 Oct; 29(4):249-54. PubMed ID: 2594021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimal liver disease in young persons with homozygous and heterozygous alpha-1-antitrypsin deficiency.
    Hultcrantz R; Jelf E; Nilsson LH
    Scand J Gastroenterol; 1984 May; 19(3):389-93. PubMed ID: 6610920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative radicals and liver involvement of infants with alpha-1-antitrypsin deficiency.
    Pittschieler K
    Padiatr Padol; 1991; 26(5):235-7. PubMed ID: 1663223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-1 antitrypsin deficiency in patients with chronic hepatitis.
    Şımşek H; Pinar A; Altinbaş A; Alp A; Balaban YH; Büyükaşik Y; Özcebe O; Hasçelık G; Gedıkoğlu G; Tatar G
    Turk J Gastroenterol; 2012; 23(5):569-73. PubMed ID: 23161303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of morphological changes after transplantation of a liver with heterozygous α-1 antitrypsin deficiency.
    Lee SM; Speeg KV; Pollack MS; Sharkey FE
    Hum Pathol; 2012 May; 43(5):753-6. PubMed ID: 22154055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatic lesions caused by alpha 1-antitrypsin deficiency in childhood. Review of 14 cases].
    Mellado MJ; Jara P; Valverde F; Díaz MC; Fuentes E; Larrauri J; Vázquez C
    An Esp Pediatr; 1986 Jul; 25(1):5-12. PubMed ID: 3489428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 39-year-old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis.
    Bacon BR; Fried MW; DiBisceglie AM
    Semin Liver Dis; 1993 Feb; 13(1):101-5. PubMed ID: 8446904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha is effective in the treatment of chronic hepatitis C.
    Worman HJ
    Am J Gastroenterol; 1995 Apr; 90(4):679-80. PubMed ID: 7717348
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha-1-antitrypsin deficiency: rare cause of adult cirrhosis--a case report.
    Tucker LE; Rawson PG
    Mo Med; 1993 Jan; 90(1):27-30. PubMed ID: 8421451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.